| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 03:32:02 UTC |
|---|
| Update Date | 2022-11-30 19:26:02 UTC |
|---|
| HMDB ID | HMDB0115076 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(20:0/20:1(11Z)) |
|---|
| Description | PA(20:0/20:1(11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/20:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCC\C=C/CCCCCCCC InChI=1S/C43H83O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-42(44)49-39-41(40-50-52(46,47)48)51-43(45)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h18,20,41H,3-17,19,21-40H2,1-2H3,(H2,46,47,48)/b20-18-/t41-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Arachidoyl-2-eicosenoyl-sn-glycero-3-phosphate | HMDB | | 1-Arachidoyl-2-eicosenoyl-sn-phosphatidic acid | HMDB | | PA(20:0/20:1) | HMDB | | PA(20:0/20:1N9) | HMDB | | PA(20:0/20:1W9) | HMDB | | PA(40:1) | HMDB | | Phosphatidic acid(20:0/20:1(11Z)) | HMDB | | Phosphatidic acid(20:0/20:1) | HMDB | | Phosphatidic acid(20:0/20:1n9) | HMDB | | Phosphatidic acid(20:0/20:1W9) | HMDB | | Phosphatidic acid(40:1) | HMDB | | Phosphatidate(20:0/20:1(11Z)) | HMDB | | Phosphatidate(20:0/20:1) | HMDB | | Phosphatidate(20:0/20:1N9) | HMDB | | Phosphatidate(20:0/20:1W9) | HMDB | | Phosphatidate(40:1) | HMDB | | 1-arachidoyl-2-eicosenoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-arachidoyl-2-eicosenoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(20:0/20:1) | SMPDB, HMDB | | PA(20:0/20:1n9) | SMPDB, HMDB | | PA(20:0/20:1w9) | SMPDB, HMDB | | PA(40:1) | SMPDB, HMDB | | Phosphatidic acid(20:0/20:1(11Z)) | SMPDB, HMDB | | Phosphatidic acid(20:0/20:1) | SMPDB, HMDB | | Phosphatidic acid(20:0/20:1n9) | SMPDB, HMDB | | Phosphatidic acid(20:0/20:1w9) | SMPDB, HMDB | | Phosphatidic acid(40:1) | SMPDB, HMDB | | Phosphatidate(20:0/20:1(11Z)) | SMPDB, HMDB | | Phosphatidate(20:0/20:1) | SMPDB, HMDB | | Phosphatidate(20:0/20:1n9) | SMPDB, HMDB | | Phosphatidate(20:0/20:1w9) | SMPDB, HMDB | | PA(20:0/20:1(11Z)) | SMPDB |
|
|---|
| Chemical Formula | C43H83O8P |
|---|
| Average Molecular Weight | 759.103 |
|---|
| Monoisotopic Molecular Weight | 758.582556631 |
|---|
| IUPAC Name | [(2R)-2-[(11Z)-icos-11-enoyloxy]-3-(icosanoyloxy)propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-2-[(11Z)-icos-11-enoyloxy]-3-(icosanoyloxy)propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCCCCCCCC\C=C/CCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C43H83O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-42(44)49-39-41(40-50-52(46,47)48)51-43(45)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h18,20,41H,3-17,19,21-40H2,1-2H3,(H2,46,47,48)/b20-18-/t41-/m1/s1 |
|---|
| InChI Key | BYNXLLKAMUQABO-NKMJREGQSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/24:1(15Z)) (PathBank: SMP0067466)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0076209)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0076210)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0076211)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0076212)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/24:0) (PathBank: SMP0076213)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0091476)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0091477)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0091478)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(11Z)/22:1(13Z)) (PathBank: SMP0099945)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/22:0/22:0) (PathBank: SMP0099953)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:1(11Z)) (PathBank: SMP0067451)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:2(11Z,14Z)) (PathBank: SMP0067452)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0067457)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/22:1(13Z)) (PathBank: SMP0067459)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0076201)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/22:0) (PathBank: SMP0076206)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/22:2(13Z,16Z)) (PathBank: SMP0076208)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(11Z)/22:0) (PathBank: SMP0099944)
- Phosphatidylcholine Biosynthesis PC(20:0/20:1(11Z)) (PathBank: SMP0063882)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0099955)
- Phosphatidylethanolamine Biosynthesis PE(20:0/20:1(11Z)) (PathBank: SMP0071784)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(11Z)/20:1(11Z)) (PathBank: SMP0099941)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/22:0/22:1(13Z)) (PathBank: SMP0099954)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/20:0) (PathBank: SMP0019113)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/14:1(9Z)) (PathBank: SMP0019116)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/16:1(9Z)) (PathBank: SMP0019117)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/18:1(11Z)) (PathBank: SMP0019118)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/18:1(9Z)) (PathBank: SMP0019119)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/18:2(9Z,12Z)) (PathBank: SMP0019123)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0019124)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0019128)
- De Novo Triacylglycerol Biosynthesis TG(20:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0019129)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(11Z)/20:1(13Z)) (PathBank: SMP0082179)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(13Z)/20:1(13Z)) (PathBank: SMP0082182)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(13Z)/22:0) (PathBank: SMP0082183)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(13Z)/22:1(13Z)) (PathBank: SMP0082184)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099942)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099943)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0099946)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099947)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0099948)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0099949)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0099950)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0099951)
- Cardiolipin Biosynthesis CL(20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0099952)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 9.13 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 39.2657 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.12 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5569.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 701.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 410.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 285.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1134.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1935.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1622.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 248.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3956.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1184.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 3129.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1508.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 787.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 824.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 907.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(20:0/20:1(11Z)),1TMS,isomer #1 | CCCCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 5369.8 | Semi standard non polar | 33892256 | | PA(20:0/20:1(11Z)),1TMS,isomer #1 | CCCCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4735.3 | Standard non polar | 33892256 | | PA(20:0/20:1(11Z)),1TMS,isomer #1 | CCCCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 6190.6 | Standard polar | 33892256 | | PA(20:0/20:1(11Z)),1TBDMS,isomer #1 | CCCCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5619.2 | Semi standard non polar | 33892256 | | PA(20:0/20:1(11Z)),1TBDMS,isomer #1 | CCCCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4827.2 | Standard non polar | 33892256 | | PA(20:0/20:1(11Z)),1TBDMS,isomer #1 | CCCCCCCC/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 6160.8 | Standard polar | 33892256 |
|
|---|
| MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 10V, Positive-QTOF | splash10-0002-1153903700-92704a11f4064c42bccf | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 20V, Positive-QTOF | splash10-0002-3294504200-6446d41086a202de57fb | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 40V, Positive-QTOF | splash10-0uxr-1179115100-a6ea509d0ae81f7316e9 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 10V, Negative-QTOF | splash10-08i4-8079800600-63b76e590a0d934c4df6 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 20V, Negative-QTOF | splash10-004i-9022000000-2aeae2e72d9a13e0f73b | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 40V, Negative-QTOF | splash10-004i-9000000000-7ee1f6a1661072a67e09 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 10V, Positive-QTOF | splash10-052f-0000000900-540cfac6970230e32fac | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 20V, Positive-QTOF | splash10-0bt9-0000005900-17a866e7ada6cfea5623 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 40V, Positive-QTOF | splash10-01ot-0000906200-8565ee7456c9d6641375 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 10V, Positive-QTOF | splash10-001i-0000000900-c739ae06c037ae9254ce | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 20V, Positive-QTOF | splash10-001i-0000009900-eaeda140a740dcc44fcd | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 40V, Positive-QTOF | splash10-00sr-0000902300-5dc669ae220455713cb4 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 10V, Negative-QTOF | splash10-0a4i-0000000900-942ad965209c5d0744ca | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 20V, Negative-QTOF | splash10-0btb-0006900400-ceee7e7b41dc077bbd08 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PA(20:0/20:1(11Z)) 40V, Negative-QTOF | splash10-08fr-0009300000-fb6395e704a59f942ff8 | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Moritz A, De Graan PN, Gispen WH, Wirtz KW: Phosphatidic acid is a specific activator of phosphatidylinositol-4-phosphate kinase. J Biol Chem. 1992 Apr 15;267(11):7207-10. [PubMed:1313792 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Divecha N, Irvine RF: Phospholipid signaling. Cell. 1995 Jan 27;80(2):269-78. [PubMed:7834746 ]
- Moolenaar WH, Kruijer W, Tilly BC, Verlaan I, Bierman AJ, de Laat SW: Growth factor-like action of phosphatidic acid. Nature. 1986 Sep 11-17;323(6084):171-3. [PubMed:3748188 ]
- Yang CY, Frohman MA: Mitochondria: signaling with phosphatidic acid. Int J Biochem Cell Biol. 2012 Aug;44(8):1346-50. doi: 10.1016/j.biocel.2012.05.006. Epub 2012 May 15. [PubMed:22609101 ]
- Cevc, Gregor (1993). Phospholipids Handbook. Marcel Dekker.
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
|---|